Welcome to the July edition of HR Hot Topics. I’m back from an extended trip ‘Out West’ and have been getting questions on how to find qualified talent in the wake of COVID. Hiring has always been one of the top three HR issues that employers struggle with, but in our current market, it […]
Welcome to the June edition of HR Hot Topics. In this month’s episode I unpack the latest round of MIOSHA emergency rules and discuss how they impact you and your business. We are no stranger to changes in safety rules as a result of COVID-19, but this most recent change lifting mask restrictions (among other […]
Welcome to the May edition of HR Hot Topics. In this month’s episode we’re talking vaccines…again. The questions I receive on this topic continue to evolve as the compliance rates, eligibility criteria and CDC guidance change. Most recently, I’ve been asked a lot about whether or not an employer can incentivize employees to get […]
In this month’s episode I provide an overview of two important changes brought about by the recently passed American Rescue Plan Act. This $1.9 trillion dollar package extends optional FFCRA leave and the associated tax credits through September 30th of this year. Additionally, the FFCRA reasons for approved leave have been expanded to include time […]
Welcome to the March edition of HR Hot Topics. Spring (false spring) is upon us here in Michigan and with that comes thoughts of spring break and vacations to someplace warm! Now that vaccines are becoming more widely available, employers are starting to question whether or not to update their travel and quarantine policies accordingly. […]
Hello Leaders! I’m taking a small break from discussing COVID (you’re welcome!) and instead want to use this month’s episode share to some exciting news happening at HRM.
Hello Leaders! Welcome to 2021! This year has already gotten off to an eventful start and the issues that employers must grapple with in the workplace show no signs of slowing down anytime soon. In this month’s episode I continue the conversation on coronavirus vaccines. Now that both Pfizer and Moderna have received emergency use […]